Search Count: 19
 |
(Apo)Alpha-Synuclein Fibril Structures From Msa Patient Brain
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-11-12 Classification: STRUCTURAL PROTEIN |
 |
Complex Fibril Structure Of Msa Alpha-Synuclein With Cns-11G At 4 Hours
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-11-12 Classification: STRUCTURAL PROTEIN Ligands: A1BGB |
 |
Complex Fibril Structure Of Msa Alpha-Synuclein With Cns-11G At 6 Hours
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-11-12 Classification: STRUCTURAL PROTEIN Ligands: A1BGB |
 |
Complex Fibril Structure Of Msa Alpha-Synuclein With Cns-11G At 10 Hours
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-11-12 Classification: STRUCTURAL PROTEIN Ligands: A1BGB |
 |
Complex Fibril Structure Of Msa Alpha-Synuclein With Cns-11G At 15 Hours
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-11-12 Classification: STRUCTURAL PROTEIN Ligands: A1BGB |
 |
Yoph W354Y Yersinia Enterocolitica Ptpase Apo Form
Organism: Yersinia enterocolitica
Method: X-RAY DIFFRACTION Resolution:1.05 Å Release Date: 2015-10-28 Classification: HYDROLASE Ligands: ACT, SO4 |
 |
Yoph W354H Yersinia Enterocolitica Ptpase In The Apo Form
Organism: Yersinia enterocolitica
Method: X-RAY DIFFRACTION Resolution:1.20 Å Release Date: 2015-10-28 Classification: HYDROLASE Ligands: GOL, ACT |
 |
Yoph W354H Yersinia Enterocolitica Ptpase Bond With Divanadate Glycerol Ester In The Active Site
Organism: Yersinia enterocolitica
Method: X-RAY DIFFRACTION Resolution:1.12 Å Release Date: 2015-10-28 Classification: HYDROLASE Ligands: DVG, VO4 |
 |
Yoph W354Y Yersinia Enterocolitica Ptpase Bond With Divanadate Glycerol Ester In The Active Site
Organism: Yersinia enterocolitica
Method: X-RAY DIFFRACTION Resolution:1.12 Å Release Date: 2015-10-28 Classification: HYDROLASE/INHIBITOR Ligands: DVG, VO4, ACT, GOL |
 |
Human Dck C4S-S74E Mutant In Complex With Udp And The Inhibitor 6 {2-[5-(4-{[(4,6-Diaminopyrimidin-2-Yl)Sulfanyl]Methyl}-5-Propyl-1,3-Thiazol-2-Yl)-2-Methoxyphenoxy]Ethanol}
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2015-02-18 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 2XZ, UDP |
 |
Human Dck C4S-S74E Mutant In Complex With Udp And The Inhibitor 7 {N-(2-(3-(4-(((4,6-Diaminopyrimidin-2-Yl)Thio)Methyl)-5-Propylthiazol-2-Yl)Phenoxy)Ethyl)Methanesulfonamide}
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2015-02-18 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 2Y0, UDP |
 |
Human Dck C4S-S74E Mutant In Complex With Udp And The Inhibitor 9 {2-{[(1R)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3-Thiazol-4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2015-02-18 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 2Y1, UDP |
 |
Human Dck C4S-S74E Mutant In Complex With Udp And The Inhibitor 4 [1-[5-(4-{[(2,6-Diaminopyrimidin-4-Yl)Sulfanyl]Methyl}-5-Propyl-1,3-Thiazol-2-Yl)-2-Methoxyphenoxy]-2-Methylpropan-2-Ol]
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2014-11-05 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 2XJ, UDP |
 |
Human Dck C4S-S74E Mutant In Complex With Udp And The Inhibitor 5 {5-(4-{[(4,6-Diaminopyrimidin-2-Yl)Sulfanyl]Methyl}-5-Propyl-1,3-Thiazol-2-Yl)-2-Methoxyphenol}
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2014-11-05 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 2XL, UDP |
 |
Human Dck C4S-S74E Mutant In Complex With Udp And The Inhibitor 8 {2,2'-[{4-[(2R)-4-{[(4,6-Diaminopyrimidin-2-Yl)Sulfanyl]Methyl}-5-Propyl-2,3-Dihydro-1,3-Thiazol-2-Yl]Benzene-1,2-Diyl}Bis(Oxy)]Diethanol}
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2014-11-05 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 2XM, UDP |
 |
Human Dck C4S-S74E Mutant In Complex With Udp And The Inhibitor 10 {2-{[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3-Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2014-11-05 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 2Y8, 2Y7, UDP |
 |
Human Dck C4S-S74E Mutant In Complex With Udp And The Inhibitor 12R {N-{2-[5-(4-{(1R)-1-[(4,6-Diaminopyrimidin-2-Yl)Sulfanyl]Ethyl}-5-Methyl-1,3-Thiazol-2-Yl)-2-Methoxyphenoxy]Ethyl}Methanesulfonamide}
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2014-11-05 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: UDP, 2XN |
 |
Human Dck C4S-S74E Mutant In Complex With Udp And The F2.2.1 Inhibitor (2-[({2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3-Thiazol-4-Yl}Methyl)Sulfanyl]Pyrimidine-4,6-Diamine)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2013-09-18 Classification: transferase/transferase inhibitor Ligands: UDP, 1NO |
 |
Human Dck C4S-S74E Mutant In Complex With Udp And The Di-43 Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2013-09-18 Classification: transferase/transferase inhibitor Ligands: 1UX, UDP |